Protagen Collaborating With UCSF on Prostate Cancer Immunotherapy Work – 360Dx
|
Protagen Collaborating With UCSF on Prostate Cancer Immunotherapy Work
360Dx NEW YORK (360Dx) – Protagen said today it has entered a collaboration with the University of California, San Francisco to use the company’s SeroTag platform for research into immunotherapies for prostate cancer. The collaboration will use Protagen’s … Protagen AG Collaborates with UCSF to Study Better Immuno-Profiling of Cancer Patients Receiving ImmunotherapyFort Bend Herald |
Futurity: Research News |
Implanting stem cell ‘patch’ can restore vision
Futurity: Research News Researchers have developed a specially engineered retinal patch to treat people with sudden, severe sight loss. In July 2015, 86-year-old Douglas Waters developed severe age-related macular degeneration. He struggled to see things clearly, even when up … Suffering from severe osteoarthritis? Stem cell therapy can helpPalm Beach Post Stem Cell Therapy Market Fabricating opportunities 2025Technical Progress Hematopoietic Stem Cell Transplantation (HSCT) Sales market to grow at a CAGR of 10-15% till 2024Expert Consulting Information-Analytic Agency NEWS.am all 37 news articles » |
|
New CAR T case study shows promise in acute myeloid leukemia
EurekAlert (press release) Chimeric Antigen Receptor T–cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient’s own immune cells to fight cancer … |
|
New CAR T case study shows promise in acute myeloid leukemia
EurekAlert (press release) Chimeric Antigen Receptor T–cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient’s own immune cells to fight cancer … |
Immuno-Oncology News |
Researchers May Now Predict Which CLL Patients Will Respond to Kymriah CAR T-Cell Therapy, Study Says
Immuno-Oncology News This immuno-oncology treatment is developed using the patient’s own T-cells to target proteins located on the surface of cancer cells. Researchers from the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) and Novartis have … |
Immuno-Oncology News |
Researchers May Now Predict Which CLL Patients Will Respond to Kymriah CAR T-Cell Therapy, Study Says
Immuno-Oncology News This immuno-oncology treatment is developed using the patient’s own T-cells to target proteins located on the surface of cancer cells. Researchers from the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) and Novartis have … |
|
3 Key Takeaways from Immunotherapy Expert Teleconference
Asbestos.com (blog) If you’ve already received standard of care and related treatments or you’re considering clinical trials, you may be interested in learning more about immunotherapy. A free immunotherapy teleconference is a great place to start. CancerCare recently … |